---
document_datetime: 2025-12-02 06:37:27
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/tritanrix-hepb.html
document_name: tritanrix-hepb.html
version: success
processing_time: 0.0993658
conversion_datetime: 2025-12-25 09:41:57.973603
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Tritanrix HepB

[RSS](/en/individual-human-medicine.xml/65560)

##### Lapsed

This medicine's authorisation has lapsed

diphtheria (D), tetanus (T), pertussis (whole cell) (Pw) and hepatitis B (rDNA) (HBV) vaccine (adsorbed) Medicine Human Lapsed

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 1 January 2014, the marketing authorisation of Tritanrix HepB (diphtheria, tetanus, pertussis (whole cell) and hepatitis-B (rDNA) vaccine (adsorbed)) ceased to be valid in the EU. The cessation of validity is in accordance with provisions of the sunset clause1 , which stipulate that the marketing authorisation of a medicinal product lapses if the product has not been marketed in any EU Member States for three consecutive years. The former marketing authorisation holder, GlaxoSmithKline Biologicals, permanently discontinued marketing of Tritanrix HepB in the EU in 2009. The European Commission had granted an exemption from the 'sunset clause' for Tritanrix HepB; however the exemption expired at the end of 2013.

GlaxoSmithKline Biologicals confirmed that it discontinued the marketing of the product due to the lack of demand in the EU. Of note, the company has submitted an application under Article 58 of Regulation (EC) No 726/2004 for an identical product, Tritanrix HB, in order to ensure supply in some countries outside the EU where this vaccine is still used. A positive CHMP Opinion for this application was adopted on 19 December 2013. Tritanrix HepB was granted marketing authorisation in the EU on 19 July 1996 and later obtained WHO pre-qualification. Tritanrix HepB was indicated for the active immunisation of infants from 6 weeks of age against diphtheria, tetanus, pertussis and hepatitis B. The marketing authorisation was initially valid for a 5-year period. It was subsequently renewed for an additional 5-year period in 2001, and granted unlimited validity in 2006.

The European Public Assessment Report for Tritanrix HepB is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Tritanrix HepB : EPAR - Summary for the public

English (EN) (948.08 KB - PDF)

**First published:** 09/06/2008

**Last updated:** 07/01/2014

[View](/en/documents/overview/tritanrix-hepb-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-854)

български (BG) (660.97 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/bg/documents/overview/tritanrix-hepb-epar-summary-public_bg.pdf)

español (ES) (489.45 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/es/documents/overview/tritanrix-hepb-epar-summary-public_es.pdf)

čeština (CS) (629.66 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/cs/documents/overview/tritanrix-hepb-epar-summary-public_cs.pdf)

dansk (DA) (489.29 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/da/documents/overview/tritanrix-hepb-epar-summary-public_da.pdf)

Deutsch (DE) (492.7 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/de/documents/overview/tritanrix-hepb-epar-summary-public_de.pdf)

eesti keel (ET) (488.86 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/et/documents/overview/tritanrix-hepb-epar-summary-public_et.pdf)

ελληνικά (EL) (679.19 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/el/documents/overview/tritanrix-hepb-epar-summary-public_el.pdf)

français (FR) (489.66 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/fr/documents/overview/tritanrix-hepb-epar-summary-public_fr.pdf)

italiano (IT) (489.24 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/it/documents/overview/tritanrix-hepb-epar-summary-public_it.pdf)

latviešu valoda (LV) (636.08 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/lv/documents/overview/tritanrix-hepb-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (603.39 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/lt/documents/overview/tritanrix-hepb-epar-summary-public_lt.pdf)

magyar (HU) (623.82 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/hu/documents/overview/tritanrix-hepb-epar-summary-public_hu.pdf)

Malti (MT) (632.55 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/mt/documents/overview/tritanrix-hepb-epar-summary-public_mt.pdf)

Nederlands (NL) (489.3 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/nl/documents/overview/tritanrix-hepb-epar-summary-public_nl.pdf)

polski (PL) (653.87 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/pl/documents/overview/tritanrix-hepb-epar-summary-public_pl.pdf)

português (PT) (489.6 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/pt/documents/overview/tritanrix-hepb-epar-summary-public_pt.pdf)

română (RO) (597.51 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/ro/documents/overview/tritanrix-hepb-epar-summary-public_ro.pdf)

slovenčina (SK) (630.01 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/sk/documents/overview/tritanrix-hepb-epar-summary-public_sk.pdf)

slovenščina (SL) (620.81 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/sl/documents/overview/tritanrix-hepb-epar-summary-public_sl.pdf)

Suomi (FI) (489.16 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/fi/documents/overview/tritanrix-hepb-epar-summary-public_fi.pdf)

svenska (SV) (488.78 KB - PDF)

**First published:**

09/06/2008

**Last updated:**

07/01/2014

[View](/sv/documents/overview/tritanrix-hepb-epar-summary-public_sv.pdf)

## Product information

Tritanrix HepB : EPAR - Product Information

English (EN) (1.32 MB - PDF)

**First published:** 10/02/2009

**Last updated:** 07/01/2014

[View](/en/documents/product-information/tritanrix-hepb-epar-product-information_en.pdf)

[Other languages (23)](#file-language-dropdown-1000)

български (BG) (1.7 MB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/bg/documents/product-information/tritanrix-hepb-epar-product-information_bg.pdf)

español (ES) (762.26 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/es/documents/product-information/tritanrix-hepb-epar-product-information_es.pdf)

čeština (CS) (1.3 MB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/cs/documents/product-information/tritanrix-hepb-epar-product-information_cs.pdf)

dansk (DA) (756.74 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/da/documents/product-information/tritanrix-hepb-epar-product-information_da.pdf)

Deutsch (DE) (762.15 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/de/documents/product-information/tritanrix-hepb-epar-product-information_de.pdf)

eesti keel (ET) (752.49 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/et/documents/product-information/tritanrix-hepb-epar-product-information_et.pdf)

ελληνικά (EL) (1.7 MB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/el/documents/product-information/tritanrix-hepb-epar-product-information_el.pdf)

français (FR) (754.65 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/fr/documents/product-information/tritanrix-hepb-epar-product-information_fr.pdf)

íslenska (IS) (868.32 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/is/documents/product-information/tritanrix-hepb-epar-product-information_is.pdf)

italiano (IT) (780.56 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/it/documents/product-information/tritanrix-hepb-epar-product-information_it.pdf)

latviešu valoda (LV) (1.36 MB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/lv/documents/product-information/tritanrix-hepb-epar-product-information_lv.pdf)

lietuvių kalba (LT) (812.63 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/lt/documents/product-information/tritanrix-hepb-epar-product-information_lt.pdf)

magyar (HU) (1.26 MB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/hu/documents/product-information/tritanrix-hepb-epar-product-information_hu.pdf)

Malti (MT) (1.37 MB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/mt/documents/product-information/tritanrix-hepb-epar-product-information_mt.pdf)

Nederlands (NL) (759.4 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/nl/documents/product-information/tritanrix-hepb-epar-product-information_nl.pdf)

norsk (NO) (855.16 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/no/documents/product-information/tritanrix-hepb-epar-product-information_no.pdf)

polski (PL) (1.31 MB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/pl/documents/product-information/tritanrix-hepb-epar-product-information_pl.pdf)

português (PT) (754.74 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/pt/documents/product-information/tritanrix-hepb-epar-product-information_pt.pdf)

română (RO) (786.88 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/ro/documents/product-information/tritanrix-hepb-epar-product-information_ro.pdf)

slovenčina (SK) (1.29 MB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/sk/documents/product-information/tritanrix-hepb-epar-product-information_sk.pdf)

slovenščina (SL) (1.29 MB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/sl/documents/product-information/tritanrix-hepb-epar-product-information_sl.pdf)

Suomi (FI) (743.06 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/fi/documents/product-information/tritanrix-hepb-epar-product-information_fi.pdf)

svenska (SV) (752.94 KB - PDF)

**First published:**

10/02/2009

**Last updated:**

07/01/2014

[View](/sv/documents/product-information/tritanrix-hepb-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0049 01/01/2014

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Tritanrix HepB : EPAR - All Authorised presentations

English (EN) (967.01 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 07/01/2014

[View](/en/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-855)

български (BG) (570.71 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/bg/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_bg.pdf)

español (ES) (528.21 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/es/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_es.pdf)

čeština (CS) (565.63 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/cs/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (517.53 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/da/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (518.62 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/de/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (536.48 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/et/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (558.34 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/el/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_el.pdf)

français (FR) (529.74 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/fr/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (512.69 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/it/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (565.75 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/lv/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (552.12 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/lt/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (562.82 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/hu/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (555.6 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/mt/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (515.84 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/nl/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_nl.pdf)

polski (PL) (568.04 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/pl/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_pl.pdf)

português (PT) (528.66 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/pt/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_pt.pdf)

română (RO) (537.24 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/ro/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (566.06 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/sk/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (559.84 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/sl/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (527.91 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/fi/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (516.23 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

07/01/2014

[View](/sv/documents/all-authorised-presentations/tritanrix-hepb-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Tritanrix HepB Active substance

- Diphtheria toxoid
- hepatitis B surface antigen
- Bordetella pertussis (inactivated)
- tetanus toxoid

International non-proprietary name (INN) or common name diphtheria (D), tetanus (T), pertussis (whole cell) (Pw) and hepatitis B (rDNA) (HBV) vaccine (adsorbed) Therapeutic area (MeSH)

- Hepatitis B
- Tetanus
- Immunization
- Whooping Cough
- Diphtheria

Anatomical therapeutic chemical (ATC) code J07CA05

### Pharmacotherapeutic group

Vaccines

### Therapeutic indication

Tritanrix HepB is indicated for active immunisation against diphtheria, tetanus, pertussis and hepatitis B (HBV) in infants from six weeks onwards (see section 4.2).

## Authorisation details

EMA product number EMEA/H/C/000093 Marketing authorisation holder

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut, 89

Marketing authorisation issued 19/07/1996 Lapse of marketing authorisation 01/01/2014 Revision 15

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Tritanrix HepB : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (655.53 KB - PDF)

**First published:** 10/02/2009

**Last updated:** 07/01/2014

[View](/en/documents/procedural-steps-after/tritanrix-hepb-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Tritanrix HepB-H-C-93-P45-39 : EPAR - Assessment Report

Adopted

Reference Number: EMA/151321/2013

English (EN) (711.13 KB - PDF)

**First published:** 09/04/2013

**Last updated:** 07/01/2014

[View](/en/documents/variation-report/tritanrix-hepb-h-c-93-p45-39-epar-assessment-report_en.pdf)

Tritanrix HepB : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (1006.24 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 07/01/2014

[View](/en/documents/steps-after-cutoff/tritanrix-hepb-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Tritanrix HepB : EPAR - Procedural steps taken before authorisation

English (EN) (1011.77 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 07/01/2014

[View](/en/documents/procedural-steps/tritanrix-hepb-epar-procedural-steps-taken-authorisation_en.pdf)

Tritanrix HepB : EPAR - Scientific Discussion

English (EN) (124.68 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 21/10/2005

[View](/en/documents/scientific-discussion/tritanrix-hepb-epar-scientific-discussion_en.pdf)

**This page was last updated on** 07/01/2014

## Share this page

[Back to top](#main-content)